Physician profile
Ryan Smith
NPI 1003017468
$16,214.19
in general payments reported to CMS, 2019-2025
37 companies · $3,715 in 2025
The $3,715 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,507 · 2020: $511 · 2021: $2,244 · 2022: $2,245 · 2023: $2,346 · 2024: $2,647 · 2025: $3,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,707.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,154.99 | 2019-2025 | Clareon, Unity, Hydrus Microstent |
| Glaukos Corporation | $2,301.19 | 2019-2025 | Idosetr, Idose, Iaccess Precision Blade |
| Sun Pharmaceutical Industries INC. | $1,939.44 | 2019-2025 | Cequa |
| Kala Pharmaceuticals, INC. | $566.86 | 2019-2022 | |
| New World Medical,INC. | $552.93 | 2019-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Bausch & Lomb Americas INC. | $501.52 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Miebo |
| Novartis Pharmaceuticals Corporation | $494.50 | 2019-2023 | |
| Allergan, INC. | $446.41 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $424.71 | 2021-2025 | Acthar |
| Ivantis, INC | $375.26 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $360.15 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $351.37 | 2022-2025 | Tyrvaya |
| Abbvie INC. | $315.76 | 2022-2025 | Lumigan |
| Dompe US, INC. | $290.88 | 2021-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $289.57 | 2019-2025 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $229.65 | 2019-2024 | Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.87 | 2019-2021 | |
| Microsurgical Technology, INC. | $181.37 | 2025 | |
| Eyevance Pharmaceuticals LLC | $154.12 | 2021-2022 | |
| Harrow Eye, LLC | $149.94 | 2024 | Iheezo |
| Rxsight INC | $133.67 | 2022-2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $108.29 | 2019-2021 | |
| Genentech, INC. | $104.72 | 2022 | |
| Sight Sciences, INC. | $93.69 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Nova Eye, INC. | $77.70 | 2024 | |
| Ocular Therapeutix, INC. | $74.46 | 2019-2025 | Dextenza |
| Shire North American Group INC | $63.41 | 2019 | |
| Amgen INC. | $58.63 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $40.00 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $33.07 | 2023 | Clarus |
| Iridex Corporation | $29.55 | 2019 | |
| Carl Zeiss Meditec, INC. | $22.22 | 2019 | |
| Eyepoint US, INC. | $20.30 | 2019 | |
| Halozyme INC | $19.72 | 2023 | |
| Aerie Pharmaceuticals, INC. | $17.06 | 2019 | |
| Horizon Therapeutics Plc | $14.97 | 2023 | Tepezza |
| Omeros Corporation | $14.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.